NTRP vs. HPCO, CLEU, SGBX, MICS, CASA, TRNR, NVFY, BON, SBET, and IDW
Should you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include Hempacco (HPCO), China Liberal Education (CLEU), Safe & Green (SGBX), Singing Machine (MICS), Casa Systems (CASA), Interactive Strength (TRNR), Nova LifeStyle (NVFY), Bon Natural Life (BON), SharpLink Gaming (SBET), and IDW Media (IDW). These companies are all part of the "consumer discretionary" sector.
Hempacco (NASDAQ:HPCO) and Neurotrope (NASDAQ:NTRP) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk.
7.6% of Hempacco shares are held by institutional investors. Comparatively, 3.8% of Neurotrope shares are held by institutional investors. 58.8% of Hempacco shares are held by insiders. Comparatively, 9.7% of Neurotrope shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Hempacco has higher revenue and earnings than Neurotrope. Neurotrope is trading at a lower price-to-earnings ratio than Hempacco, indicating that it is currently the more affordable of the two stocks.
In the previous week, Hempacco had 1 more articles in the media than Neurotrope. MarketBeat recorded 2 mentions for Hempacco and 1 mentions for Neurotrope. Hempacco's average media sentiment score of 0.00 beat Neurotrope's score of -0.27 indicating that Neurotrope is being referred to more favorably in the news media.
Hempacco has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, Neurotrope has a beta of 1.54, indicating that its stock price is 54% more volatile than the S&P 500.
Neurotrope received 180 more outperform votes than Hempacco when rated by MarketBeat users.
Hempacco has a net margin of -439.42% compared to Hempacco's net margin of -1,123.90%. Neurotrope's return on equity of -113.86% beat Hempacco's return on equity.
Summary
Hempacco beats Neurotrope on 10 of the 14 factors compared between the two stocks.
Get Neurotrope News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neurotrope Competitors List
Related Companies and Tools
